Johnson & Johnson

J&J Pinnacle hip verdict slashed from $500M to $151M

J&J Innovation backs Gilde’s new $285M biotech fund

GSK, J&J’s RA drug pulls off clean sweep of major endpoints in PhIII trial

FDA to review Samsung’s Remicade biosim as Janssen faces further sales erosion

J&J, HP team up for 3-D printing of personalized healthcare products

Johnson & Johnson opens first international JLABs site in Canada